<DOC>
	<DOCNO>NCT01377909</DOCNO>
	<brief_summary>Objective : The goal improve peginterferon sensitivity previous poor responder . `` Sensitivity '' mean host 's ability kill HCV . Design : Twenty poor responder prior PIFN/RBV give 48 week statin monotherapy . Veterans civilian age 18 70 eligible .</brief_summary>
	<brief_title>HCV Treatment With Fluvastatin , Simvastatin Improve Interferon Sensitivity</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Hepatitis C positive HCV RNA within 180 day . No antiHCV medicine within 30 day screen decompensated liver disease severe cardiac disease ( ejection fraction &lt; 20 % uncontrolled angina ) unexplained muscle pain time screen pregnancy renal insufficiency ( creatine clearance &lt; 50 ml/min )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>chronic hepatitis C , interferon</keyword>
</DOC>